Jesper Wrangle

Selecting a Testing Partner During a Pandemic

Selecting a Testing Partner During a Pandemic

While much of the world continues to cancel events and defer projects in light of the COVID-19 pandemic, drug development often doesn't have the luxury of going on hold. Preclinical drug testing and the submissions that follow can't afford potential delays, which...

U.S. FDA Updates to Guidance on Managing Drug-Drug Interactions

U.S. FDA Updates to Guidance on Managing Drug-Drug Interactions

The recently updated guidelines on assessing drug-drug interactions will likely improve experimental outcomes, reduce costs and streamline development timelines. The U.S. FDA updated its guidelines for in vitro drug interaction assessment to help drug developers...

Virtual Audits: You Can Now Qualify Testing Sites From Home

Virtual Audits: You Can Now Qualify Testing Sites From Home

Between travel limits and social distancing, in-person visits at testing sites for drug and medical device development are currently not an option. Qualifying testing sites is a standard industry practice, but the resulting restrictions of COVID-19 present new...

The Logistics of Shipping Biological Samples During COVID-19

The Logistics of Shipping Biological Samples During COVID-19

The novel coronavirus (COVID-19) pandemic has thrown many standard procedures out the window, including how companies approach the logistics of shipping biological samples to China. To prevent the introduction and spread of infectious disease, Chinese Customs...

Keeping Your Molecule’s Timeline on Track During COVID-19

Keeping Your Molecule’s Timeline on Track During COVID-19

The unforeseen and drastic effects the COVID-19 pandemic has had on the industry have led to unanticipated challenges, including stricter international shipping regulations, travel restrictions, local lockdowns and more. However, industry leaders are still here to...

Through Partnership We Will Push Forward

Through Partnership We Will Push Forward

As your partner we are taking all the necessary steps to make sure your drug development continues without any disruptions in the process. Moving your molecule forward during COVID-19 doesn’t need to be stressful or difficult. We continue to learn and have found...

Meeting Your Aggressive Timelines

Meeting Your Aggressive Timelines

Meeting drug development timelines are highly important and the building blocks of success for drug development companies. Frequently, financing tranches are connected to the achievement of milestones, and potential strategic partners may be evaluating multiple...